Citadel Advisors’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $141K | Buy |
|
|||||
|
2025
Q2 | $63.5K | Buy |
|
|||||
|
2025
Q1 | $14.1K | Buy |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $141K | Sell |
|
|||||
|
2024
Q1 | $296K | Sell |
|
|||||
|
2023
Q4 | $268K | Sell |
|
|||||
|
2023
Q3 | $229K | Sell |
|
|||||
|
2023
Q2 | $634K | Sell |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $1.85M | Buy |
|
|||||
|
2022
Q3 | $1.31M | Sell |
|
|||||
|
2022
Q2 | $2.59M | Buy |
|
|||||
|
2022
Q1 | $9.46M | Sell |
|
|||||
|
2021
Q4 | $9.94M | Sell |
|
|||||
|
2021
Q3 | $10.7M | Sell |
|
|||||
|
2021
Q2 | $12.3M | Sell |
|
|||||
|
2021
Q1 | $23.2M | Buy |
|
|||||
|
2020
Q4 | $39.8M | Buy |
|
|||||
|
2020
Q3 | $19.9M | Buy |
|